(Q42932141)

11 November 2017

title

Cilostazol enhances macrophage reverse cholesterol transport in vitro and in vivo (English)

1 reference

11 November 2017

Kazuhiro Nakaya

1

1 reference

11 November 2017

Makoto Ayaori

2

1 reference

11 November 2017

Harumi Uto-Kondo

3

1 reference

11 November 2017

Tetsuya Hisada

4

1 reference

11 November 2017

Masatsune Ogura

5

1 reference

11 November 2017

Emi Yakushiji

6

1 reference

11 November 2017

Shunichi Takiguchi

7

1 reference

11 November 2017

Yoshio Terao

8

1 reference

11 November 2017

Hideki Ozasa

9

1 reference

11 November 2017

Makoto Sasaki

10

1 reference

11 November 2017

Tomohiro Komatsu

11

1 reference

11 November 2017

Fumitaka Ohsuzu

12

1 reference

11 November 2017

Katsunori Ikewaki

13

1 reference

11 November 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20723893

19 June 2024

publication date

27 July 2010

1 reference

full work available at URL

11 November 2017

https://api.elsevier.com/content/article/PII:S0021915010005691?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

https://api.elsevier.com/content/article/PII:S0021915010005691?httpAccept=text/plain

19 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

19 June 2024

1 reference

11 November 2017

volume

213

1 reference

11 November 2017

issue

1

1 reference

11 November 2017

page(s)

135-141

1 reference

New insights into the regulation of HDL metabolism and reverse cholesterol transport

11 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein

19 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins

19 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice

19 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo

19 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism.

19 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Cilostazol, a potent phosphodiesterase type III inhibitor, selectively increases antiatherogenic high-density lipoprotein subclass LpA-I and improves postprandial lipemia in patients with type 2 diabetes mellitus

19 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication

19 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Effects of torcetrapib in patients at high risk for coronary events

19 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines

19 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Glucocorticoid receptor regulates ATP-binding cassette transporter-A1 expression and apolipoprotein-mediated cholesterol efflux from macrophages

19 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Telmisartan enhances cholesterol efflux from THP-1 macrophages by activating PPARgamma

19 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

ATP-binding cassette transporter A1 gene transcription is downregulated by activator protein 2alpha. Doxazosin inhibits activator protein 2alpha and increases high-density lipoprotein biogenesis independent of alpha1-adrenoceptor blockade

19 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Expression of cholesteryl ester transfer protein in mice promotes macrophage reverse cholesterol transport

19 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor

19 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element

19 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Identification of the cAMP-responsive enhancer of the murine ABCA1 gene: requirement for CREB1 and STAT3/4 elements

19 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication

19 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches

19 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Inherited disorders of HDL metabolism and atherosclerosis

19 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse

19 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Expression, regulation, and activity of ABCA1 in human cell lines

19 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Cyclic AMP-specific phosphodiesterase 4 inhibitors promote ABCA1 expression and cholesterol efflux

19 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Pseudomonas aeruginosa and sPLA2 IB stimulate ABCA1-mediated phospholipid efflux via ERK-activation of PPARalpha-RXR.

19 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

19 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Effect of cilostazol, a phosphodiesterase inhibitor, on carotid IMT in Japanese type 2 diabetic patients.

19 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Cilostazol in secondary prevention of stroke: impact of the Cilostazol Stroke Prevention Study

19 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Coronary stent restenosis in patients treated with cilostazol

19 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Cilostazol reduces atherosclerosis by inhibition of superoxide and tumor necrosis factor-alpha formation in low-density lipoprotein receptor-null mice fed high cholesterol.

19 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Anti-atherosclerotic effect of cilostazol in apolipoprotein-E knockout mice

19 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Cilostazol inhibits modified low-density lipoprotein uptake and foam cell formation in mouse peritoneal macrophages

19 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I

19 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

Intestinal ABCA1 directly contributes to HDL biogenesis in vivo

19 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.07.024

19 June 2024

Identifiers

1 reference

11 November 2017

1 reference